Status:
COMPLETED
InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Conditions:
Heart Failure
Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the...
Eligibility Criteria
Inclusion
- Patients implanted with the InSync ICD or InSync Marquis cardiac resynchronization therapy (CRT) system (includes InSync ICD Model 7272 or InSync Marquis Model 7277, right atrial lead, right ventricular lead and any market released Medtronic left ventricular lead or the investigational Attain Model 4189 lead which was implanted during the MIRACLE ICD Study)
Exclusion
- Patients with a history of a previously failed placement of a currently investigational Medtronic left ventricular lead within 30 days of enrollment in the InSync ICD Registry
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00289302
Start Date
January 1 2003
End Date
December 1 2006
Last Update
October 5 2007
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Mobile, Alabama, United States
3
Phoenix, Arizona, United States
4
San Diego, California, United States